Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
TXMD logo

TXMD

NGS
TherapeuticsMD Inc.
HealthcareDrug Manufacturers - Major
Watchlists:
Last updated: Monday 14th July 2025
1.18
-0.02 (-1.67%)
Prev Close:1.2
Open:1.2
Bid:1.19
Ask:1.24
52 Week Range
0.70
2.44
Volume:48,248
Mkt Cap:14 M
Price Target
$1.36
+15.3%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

TXMD - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Basic Discontinuous Operations0.01-0.2512.29
Depreciation And Amortization509000.0922000.01 M400000.0800000.0612786.0293886.0213117.0132451.062400.0
Diluted Discontinuous Operations0.01-0.2511.84
General And Administrative Expense5 M9 M57 M81 M77 M174 M-1 M-1 M-709843.0-446099.0
Gross Profit Margin (profit Margin After CGS)2 M1 M69 M1 M49 M43 M13 M14 M15 M16 M
Interest Expense Non Operating9500.0166600.014 M23 M26 M17 M5 M
Misc Other Special Charges1 M1 M-117000.0272000.0598000.0-8 M2 M703330.0378141.095719.0
Net Income (loss)-2 M-10 M112 M-172 M-184 M-176 M-133 M-77 M-90 M-85 M
Net Income Common Stockholders-2 M-10 M112 M-79 M-184 M-176 M-133 M-77 M-90 M-85 M
Net Income Continuous Operations-2 M-8 M1 M-172 M-184 M-176 M-133 M-77 M-90 M-85 M
Net Income Discontinuous Operations131000.0-3 M111 M-93 M
Net Non Operating Interest Income Expense135400.0131300.0-13 M-33 M-29 M-17 M-5 M10824.017442.0
Normalized Income-1 M-63 M
Operating Income-5 M-9 M11 M-80 M-156 M-151 M-130 M-78 M-90 M-85 M
Operating Income Before Depreciation (EBITDA)-2 M-7 M12 M-79 M-153 M-157 M-127 M-77 M-90 M-85 M
Operating Expense7 M10 M58 M81 M204 M195 M-144 M-92 M-105 M-101 M
Other Gain Loss From Disposition Of Discontinued Operations131000.0-3 M111 M-93 M
Other Gand A5 M9 M57 M81 M77 M174 M-1 M-1 M-709843.0-446099.0
Other Impairment Of Capital Assets1 M1 M78864.0
Other Operating Expenses2 M2 M2 M2 M2 M2 M
Other Write Down275379.0
Other Write Off317000.024000.0
Promotion And Advertising13 M40 M36 M9 M-2 M-448288.0-752611.0-792574.0
Rent And Landing Fees-1 M-1 M-709843.0-446099.0
Research Expense7 M10 M20 M27 M34 M54 M72 M
Restructring And Mn A Income9 M
Salaries And Wages1 M12 M-278000.011 M11 M-9 M-7 M-17 M-7 M
Selling And Marketing Expense13 M40 M117 M9 M116 M58 M51 M29 M
Selling Expense116 M58 M51 M29 M
Total Income Available For Interest Expense (EBIT)-2 M-8 M11 M-80 M-157 M-159 M-128 M-77 M-90 M-85 M
Total Revenues2 M1 M70 M3 M65 M50 M16 M17 M19 M20 M
Total Expenses7 M10 M59 M82 M220 M201 M-146 M-94 M-110 M-105 M
Total Revenue2 M1 M70 M3 M65 M50 M16 M17 M19 M20 M
Amord4 M6 M7 M7 M41 M6 M-382333.0-71516.0-54545.0-32441.0
Avgshs11532.010 M9 M8 M6 M5 M5 M4 M4 M3 M
Avgshsdt11532.010 M9 M8 M5 M4 M4 M4 M3 M
Basiceps-0.19-0.9812.41-21.5-33.5-36.0
Basicepscont-0.2-0.740.12-21.5-33.5-36.0
Cor1 M1 M16 M6 M-3 M-3 M-4 M-5 M
Depamor509000.0922000.01 M400000.0800000.0612786.0293886.0213117.0132451.062400.0
Dileps-0.19-0.9811.95-21.5-33.5-36.0-29.5-18.5-23.0-24.5
Dilepscont-0.2-0.740.11
Intinc144900.0297900.010824.017442.0
Netincdisc-2 M-10 M112 M-172 M-184 M-176 M-133 M-77 M-90 M-85 M
Othincexp1 M-1 M-10 M-272000.0-598000.08 M-2 M-703330.0-378141.0-95719.0
Pretaxinc-2 M-8 M1 M-79 M-184 M-176 M-133 M-77 M-90 M-85 M
Resdev7 M10 M20 M27 M34 M54 M72 M
Restruct9 M
Sga5 M9 M57 M81 M194 M174 M116 M58 M51 M29 M
Shsout12 M12 M10 M9 M8 M5 M5 M4 M4 M4 M
Specincchg-9 M
Taxprov-31000.0-43000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader